Labcorp Reports Q2 2026 Results, Raises Full Year Guidance
Labcorp announced financial results for the second quarter of 2026, showing year-over-year growth in both revenue and earnings per share. The company also increased its full-year financial guidance.
Labcorp reported its financial results for the second quarter of 2026, demonstrating significant growth compared to the same period in 2025. The company's revenue increased by 5.8% to $3.73 billion, up from $3.53 billion in the prior year quarter.
Diluted earnings per share rose by 28.5% to $3.64, while adjusted earnings per share saw a 14.9% increase, reaching $4.99. These figures represent a substantial improvement over the second quarter of 2025.
Following these strong quarterly results, Labcorp has raised its financial guidance for the full year 2026. The company now anticipates higher full-year revenue growth and an improved adjusted earnings per share compared to its previous forecasts.
Specific details regarding the revised full-year outlook were not provided in the company's press release. Labcorp operates in the healthcare sector, offering diagnostic and drug development services.